These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

592 related items for PubMed ID: 21997849

  • 1. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC, Lu PL, Hsiao HH, Chang CS, Liu TC, Yang WC, Lin SF.
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [Abstract] [Full Text] [Related]

  • 2. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K.
    Transpl Infect Dis; 2010 Aug 01; 12(4):322-9. PubMed ID: 20487414
    [Abstract] [Full Text] [Related]

  • 3. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J, Liu J, Gu J, Zhu P.
    Biol Blood Marrow Transplant; 2007 Dec 01; 13(12):1417-21. PubMed ID: 18022570
    [Abstract] [Full Text] [Related]

  • 4. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG, Jakubowski A, Jaffe D, Sepkowitz K, Pamer E, O'Reilly RJ, Papanicolaou GA.
    Transpl Infect Dis; 2007 Dec 01; 9(4):286-94. PubMed ID: 17511819
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.
    Biol Blood Marrow Transplant; 2015 Nov 01; 21(11):2008-16. PubMed ID: 26211985
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM.
    Biol Blood Marrow Transplant; 2009 Sep 01; 15(9):1049-59. PubMed ID: 19660717
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.
    Piñana JL, Martino R, Barba P, Margall N, Roig MC, Valcárcel D, Sierra J, Rabella N.
    Bone Marrow Transplant; 2010 Mar 01; 45(3):534-42. PubMed ID: 19668235
    [Abstract] [Full Text] [Related]

  • 8. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):766-9. PubMed ID: 12899755
    [Abstract] [Full Text] [Related]

  • 9. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
    Wang LR, Dong LJ, Zhang MJ, Lu DP.
    Bone Marrow Transplant; 2008 Nov 10; 42(10):673-7. PubMed ID: 18695666
    [Abstract] [Full Text] [Related]

  • 10. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Zhao XS, Yu L, Han W, Zhang XH, Wang Y, Chen Y, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb 10; 30(2):77-81. PubMed ID: 19563015
    [Abstract] [Full Text] [Related]

  • 11. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.
    Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W.
    Bone Marrow Transplant; 2003 Oct 10; 32(7):695-701. PubMed ID: 13130317
    [Abstract] [Full Text] [Related]

  • 12. Interferon gamma 13-CA-repeat homozygous genotype and a low proportion of CD4(+) lymphocytes are independent risk factors for cytomegalovirus reactivation with a high number of copies in hematopoietic stem cell transplantation recipients.
    Jaskula E, Dlubek D, Duda D, Bogunia-Kubik K, Mlynarczewska A, Lange A.
    Biol Blood Marrow Transplant; 2009 Oct 10; 15(10):1296-305. PubMed ID: 19747638
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients.
    Correia-Silva Jde F, Victória JM, Guimarães AL, Salomão UE, de Abreu MH, Bittencourt H, Gomez RS.
    Oral Dis; 2007 Mar 10; 13(2):163-9. PubMed ID: 17305617
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A.
    Haematologica; 1998 Feb 10; 83(2):132-7. PubMed ID: 9549924
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease.
    Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, Halter J, Heim D, Tichelli A, Gratwohl A, Stern M.
    Biol Blood Marrow Transplant; 2010 Sep 10; 16(9):1309-14. PubMed ID: 20353832
    [Abstract] [Full Text] [Related]

  • 16. Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants.
    George B, Kerridge I, Gilroy N, Huang G, Hertzberg M, Gottlieb D, Bradstock K.
    Bone Marrow Transplant; 2010 May 10; 45(5):849-55. PubMed ID: 19915635
    [Abstract] [Full Text] [Related]

  • 17. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
    Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.
    Biol Blood Marrow Transplant; 2009 Dec 10; 15(12):1587-95. PubMed ID: 19896083
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors.
    Yoon HS, Lee JH, Choi ES, Seo JJ, Moon HN, Kim MN, Im HJ.
    Pediatr Transplant; 2009 Nov 10; 13(7):898-905. PubMed ID: 19032414
    [Abstract] [Full Text] [Related]

  • 19. L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation.
    Kimura SI, Wada H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Yamazaki R, Oshima K, Tanaka Y, Tanihara A, Nishida J, Kanda Y.
    Transpl Infect Dis; 2012 Aug 10; 14(4):364-73. PubMed ID: 22469427
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients.
    Matsumura T, Narimatsu H, Kami M, Yuji K, Kusumi E, Hori A, Murashige N, Tanaka Y, Masuoka K, Wake A, Miyakoshi S, Kanda Y, Taniguchi S.
    Biol Blood Marrow Transplant; 2007 May 10; 13(5):577-83. PubMed ID: 17448917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.